Author

Rachel Sachs

Robert I. Field is professor of law at the Kline School of Law and professor of health management and policy at the Dornsife School of Public Health at Drexel University. He is also a senior fellow of the Leonard Davis Institute of Health Economics at the University of Pennsylvania.
  • FDA

    Senator Cruz’s RESULT Act Unlikely to Achieve Results

    By Rachel Sachs On Thursday, Senators Ted Cruz and Mike Lee introduced the Reciprocity Ensures Streamlined Use of Lifesaving Treatments (RESULT) Act (text), which would require the FDA to speed review of drugs, devices, and…

    Senator Cruz’s RESULT Act Unlikely to Achieve Results

  • FDA

    FDA Releases Report Detailing Problematic Laboratory-Developed Tests

    By Rachel Sachs Last week, the FDA issued a report presenting 20 case studies of laboratory-developed tests (LDTs) that have or may have harmed patients, in support of its ongoing efforts to impose greater regulatory…

    FDA Releases Report Detailing Problematic Laboratory-Developed Tests

  • Generic Drugs

    Generic Drug Price Increases: Implications for Medicaid

    By Rachel Sachs The internet (not just the health policy part of the internet!) is fascinated by today’s New York Times story about dramatic recent increases in the costs of many decades-old drugs.  The story…

    Generic Drug Price Increases: Implications for Medicaid

  • Bioethics

    Induced Infringement in Patent Law and the Doctor-Patient Relationship

    By Rachel Sachs Regular readers of this blog will recall that I often think and write about the interaction between the induced infringement doctrine in patent law and medical method patents of various kinds (previous…

    Induced Infringement in Patent Law and the Doctor-Patient Relationship

  • Intellectual Property

    Akamai v. Limelight: Implications for Medical Method Patents (Redux)

    By Rachel Sachs Yesterday, the Court of Appeals for the Federal Circuit issued a unanimous en banc ruling in Akamai v. Limelight, altering the reach of patent liability for induced infringement of a method claim…

    Akamai v. Limelight: Implications for Medical Method Patents (Redux)

  • Health Law Policy

    House Passes 21st Century Cures Act, Including a New NIH Innovation Prize Fund

    By Rachel Sachs This morning, the House of Representatives passed the 21st Century Cures Act by a vote of 344-77, achieving a truly bipartisan result in a difficult political environment.  (I’ve blogged about the Act…

    House Passes 21st Century Cures Act, Including a New NIH Innovation Prize Fund

  • Health Care Reform

    The ACA Survives — But With A Note Of Caution For The Future?

    By Rachel Sachs Academic Fellow Rachel Sachs has a new piece up at the Health Affairs Blog discussing the Supreme Court’s decision in King v. Burwell. From the piece:  Chief Justice Roberts has once again saved a core provision…

    The ACA Survives — But With A Note Of Caution For The Future?

  • Health Care Finance

    Happy about the Supreme Court’s ACA decision? Thank a law professor

    By Rachel Sachs [Originally published on The Conversation]. The core of the Affordable Care Act (ACA) has now survived its second trip to the Supreme Court. Chief Justice John Roberts wrote for the majority in King…

    Happy about the Supreme Court’s ACA decision? Thank a law professor

  • Health Care Reform

    How law professors helped the Supreme Court understand the Affordable Care Act

    By Rachel Sachs [Originally published on The Conversation]. In March, the Supreme Court heard oral arguments in King v Burwell, a case that could broadly impact the functioning of the Affordable Care Act (ACA). The central question in King…

    How law professors helped the Supreme Court understand the Affordable Care Act

  • Biotechnology

    Ariosa v. Sequenom Invalidates the Non-Invasive Prenatal Testing Patent

    By Rachel Sachs On Friday, the Court of Appeals for the Federal Circuit affirmed the district court’s judgment of invalidity of several claims in Sequenom’s diagnostic method patent on the grounds that they were not…

    Ariosa v. Sequenom Invalidates the Non-Invasive Prenatal Testing Patent